CTRI/2018/11/016262RecruitingPhase 3
Is there a role of Gabapentin in Dystonic Cerebral Palsy?
Jaslok Hospital and Research Center0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1) Diagnosed case of dystonic cerebral palsy
- •2) Participants not on any medication for tone for last 4 weeks
- •3) Participants on stable rehabilitation programme for last 6 weeks
- •4) Participants are able to swallow the drug
- •5) Parents/ caregivers are able to understand/comply with the study trial requirements
Exclusion Criteria
- •1) Known allergy to Gabapentin and/or its ingredients
- •2) Age less than 2 years and greater than 18 years at the enrollment
Investigators
Similar Trials
Active, not recruiting
Phase 1
Baclofen pump treatment for people with dystonic cerebral palsy: a comparison of placebo and baclofedytonic cerebral palsyMedDRA version: 19.1Level: PTClassification code 10008129Term: Cerebral palsySystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2010-019768-35-NL
Completed
Not Applicable
Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trialcerebral palsyNL-OMON45097Vrije Universiteit Medisch Centrum41
Completed
Not Applicable
Intrathecal baclofen treatment in dystonic cerebral palsy: A randomized clinical trial.NL-OMON21127VU University Medical CenterMaastricht University Medical Center30
Recruiting
Not Applicable
The role of the cerebellum in fixed dystoniafixed abnormal posturing of the limbsFixed dystonia10028037NL-OMON34498niversitair Medisch Centrum Sint Radboud30
Completed
Not Applicable
etworkmodulation in Dystonia patients with Globus pallidus deep brain stimulation with H2O-PETG24DystoniaDRKS00003137niklinik KölnKlinik für Neurologie16